SARS-CoV-2 and Acetylsalicylic Acid (SARA)

NCT05073718 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV2 Infection
Covid19

Interventions

DRUG: Low-dose acetylsalicylic acid
DRUG: Placebo

Sponsor

Barcelona Institute for Global Health

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]